NeOnc Technologies (NTHI) ends Fox Infused arbitration with $737,920.77 payout

Rhea-AI Filing Summary

NeOnc Technologies Holdings, Inc. disclosed that its wholly owned subsidiary NeOnc Technologies, Inc. has fully settled a contract dispute with Fox Infused, LLC. The dispute arose after NeOnc terminated a July 1, 2022 Intellectual Property License and Supply Agreement on April 25, 2023, which led to litigation and then arbitration. The parties had agreed to settle for a $600,000 payment tied to the company’s initial public offering or March 31, 2024. On February 27, 2026, NeOnc paid Fox Infused $737,920.77, including $137,920.77 in interest, and the matter is now fully resolved.

Insights

Litigation and capital allocation analyst

NeOnc resolved a legacy contract dispute with a $737,920.77 cash payment.

The company’s subsidiary NeOnc Technologies, Inc. terminated an Intellectual Property License and Supply Agreement with Fox Infused, LLC, which triggered court proceedings and then arbitration. Instead of continuing to litigate, the parties agreed on a settlement structure tied to a future financing milestone or a date.

NeOnc ultimately paid $737,920.77, including $137,920.77 of interest, on February 27, 2026, exceeding the earlier $600,000 settlement figure. This represents a clear cash outflow to eliminate the claim. The filing states that the dispute is now settled, reducing legal uncertainty but at a direct cost to liquidity.

false 0001979414 0001979414 2026-02-26 2026-02-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported):

February 26, 2026

NEONC TECHNOLOGIES HOLDINGS, INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

001-42567		92-1954864
(Commission File Number)		(IRS Employer Identification No.)

23975 Park Sorrento, Suite 205 Calabasas, CA		91302
(Address of Principal Executive Offices)		(Zip Code)

(818) 570-6844

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbols		Name of each exchange on which registered
Common Stock, par value $0.0001		NTHI		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events

On July 1, 2022, NeOnc Technologies Holdings, Inc.’s wholly owned subsidiary, NeOnc Technologies, Inc. (“NeOnc”) and Fox Infused, LLC, a Delaware limited liability company (“Fox Infused”), entered into an Intellectual Property License and Supply Agreement effective July 1, 2022 (the “Agreement”) whereby NeOnc agreed to supply certain products to Fox Infused and license certain of its patents. NeOnc terminated the Agreement with Fox Infused on April 25, 2023.

On June 6, 2023, Fox Infused filed a complaint against NeOnc in the Central District of California alleging that the termination was improper (Civil Action No. 2:23-04431). Fox Infused also filed an ex parte application for a temporary restraining order and an order to show cause on a preliminary injunction against NeOnc seeking to have the court stop the termination of the contract. Fox Infused’s temporary restraining order application was denied and the case dismissed without prejudice. Fox Infused refiled the case in arbitration before the American Arbitration Association (Case No. 01-23-0002-5020).

The parties engaged in settlement discussions, and agreed to settle the dispute for a $600,000 payment by NeOnc to Fox Infused within 5 business days of the closing date of the Company’s initial public offering or March 31, 2024.

On February 27, 2026, NeOnc paid Fox Infused a total of $737,920.77, which included $137,920.77 in interest. As a result of such payment in full by NeOnc, the dispute has been settled.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: March 4, 2026	NeOnc Technologies Holdings, Inc.
	By:	/s/ Amir Heshmatpour
		Name:	Amir Heshmatpour
		Title:	Chief Executive Officer, President and Executive Chairman

2

FAQ

What contract dispute did NeOnc Technologies Holdings (NTHI) disclose?

NeOnc disclosed a dispute involving its subsidiary NeOnc Technologies, Inc. and Fox Infused, LLC over an Intellectual Property License and Supply Agreement dated July 1, 2022. NeOnc terminated the agreement on April 25, 2023, which led to litigation and later arbitration proceedings.

How much did NeOnc Technologies ultimately pay to settle the Fox Infused dispute?

NeOnc ultimately paid Fox Infused a total of $737,920.77. This amount included a $600,000 settlement payment plus $137,920.77 in interest, reflecting the cost of resolving the arbitration and bringing the long‑running contract dispute to a close.

When did NeOnc Technologies (NTHI) make the settlement payment to Fox Infused?

NeOnc made the settlement payment to Fox Infused on February 27, 2026. The payment of $737,920.77, which included accrued interest, followed earlier litigation and arbitration activity and satisfied the agreed settlement terms between the parties.

What were the original settlement terms between NeOnc and Fox Infused?

The parties initially agreed to settle their dispute for a $600,000 payment by NeOnc to Fox Infused. That payment was to be made within five business days of the closing of NeOnc’s initial public offering or by March 31, 2024, whichever condition applied first.

Is the Fox Infused arbitration matter now fully resolved for NeOnc Technologies?

Yes, the Fox Infused matter is now fully resolved. NeOnc’s payment of $737,920.77 on February 27, 2026 satisfied the settlement obligations, and the filing states that, as a result of this payment in full, the dispute between the parties has been settled.

What triggered the legal actions by Fox Infused against NeOnc Technologies’ subsidiary?

Fox Infused initiated legal actions after NeOnc’s subsidiary terminated their Intellectual Property License and Supply Agreement on April 25, 2023. Fox Infused first filed a complaint and sought a temporary restraining order in federal court, then refiled the dispute in arbitration after the court case was dismissed without prejudice.

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 3.0 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB